Research map: Methodological considerations on the effectiveness of biologics in asthma-COPD overlap
Back to the article
Papers in this map
The Asthma–COPD Overlap Syndrome
· Dirkje Sjoukje Postma · 2015 · 547 citations · Cited by this paper
Evaluation of the effect of modulator therapies on medication complexity in adult cystic fibrosis patients
· 2026 · Related
Effectiveness of Mepolizumab and Dupilumab in patients with asthma-COPD overlap (ACO) compared to severe uncontrolled asthma (SUA): A retrospective observational cohort study
· Belén Muñoz-Sánchez · 2026 · 3 citations · Cited by this paper
Differential distribution of ivacaftor and its metabolites in plasma and human airway epithelia
· 2024 · Related
Real-life impact of anti-IL5 therapy on exacerbation types in patients with obstructive lung disease
· Lowie E.G.W. Vanfleteren · 2025 · 3 citations · Cited by this paper
Prevalence and clinical significance of pre- and post-bronchodilator airflow obstruction in COPD patients
· 2024 · Related
Drug-drug interactions in vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor-ivacaftor
· 2025 · Related
Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammation
· 2025 · Related
Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: a randomised controlled trial
· 2025 · Related
Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment
· 2026 · Related
Clinical remission at two years post-diagnosis of asthma and its association with clinical outcomes: A retrospective cohort study in asthma patients with maintenance inhaler therapy
· 2025 · Related
m6A reader IGF2BP2 Mediates Airway Remodeling by Stabilizing Dixdc1 in Asthma Pathogenesis
· 2026 · Related
Source: OpenAlex (CC0)